CIBU PANICKER: Open Payments
NPI 1235492760 · OCEANSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$713 in 32 payments from 15 companies in 2025. Trend: 2023 $171 · 2024 $376 · 2025 $713
Food & beverage: $713
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $170 |
| Dexcom, Inc. | 4 | $106 |
| Indivior Inc. | 2 | $66 |
| Novo Nordisk Inc | 2 | $59 |
| Hologic Sales and Service, LLC | 2 | $44 |
| Corcept Therapeutics | 2 | $33 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
| Gilead Sciences, Inc. | 1 | $29 |
| PFIZER INC. | 1 | $27 |
Products named: MOUNJARO, Dexcom G6 Transmitter, SUBLOCADE, Wegovy, APTIMA, Korlym, ROTATEQ, Kerendia.
Industry payments across CA — which companies pay providers there.
